News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Daily News Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes Michael O'Riordan August 19, 2024
News Daily News Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea Michael O'Riordan June 21, 2024
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Conference News ACC 2023 Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT Yael L. Maxwell March 07, 2023
News Daily News Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care Shelley Wood May 27, 2021
News Daily News Diabetes Does Not Appear to Hinder FFR Insights for CAD Caitlin E. Cox January 09, 2020
News Daily News Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame Michael O'Riordan March 27, 2019
News Daily News Gasp! Cardiorespiratory Fitness Falling Over Time, Duke Study Suggests Michael O'Riordan January 23, 2019
News Conference News AHA 2018 Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages Michael O'Riordan November 12, 2018
News Daily News Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors Michael O'Riordan June 13, 2018
News Daily News Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry Yael L. Maxwell September 14, 2016
News Conference News ESC 2015 Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes Yael L. Maxwell September 01, 2015
News Conference News AHA 2014 FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes November 16, 2014
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012